253 related articles for article (PubMed ID: 31569614)
1. Extracellular miRNAs as Biomarkers of Head and Neck Cancer Progression and Metastasis.
Nowicka Z; Stawiski K; Tomasik B; Fendler W
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31569614
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
Wang Y; Wang J; Huang Y
Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
[TBL] [Abstract][Full Text] [Related]
3. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer.
Lajer CB; Garnæs E; Friis-Hansen L; Norrild B; Therkildsen MH; Glud M; Rossing M; Lajer H; Svane D; Skotte L; Specht L; Buchwald C; Nielsen FC
Br J Cancer; 2012 Apr; 106(9):1526-34. PubMed ID: 22472886
[TBL] [Abstract][Full Text] [Related]
4. miRNAs in head and neck cancer revisited.
Nagadia R; Pandit P; Coman WB; Cooper-White J; Punyadeera C
Cell Oncol (Dordr); 2013 Feb; 36(1):1-7. PubMed ID: 23338821
[TBL] [Abstract][Full Text] [Related]
5. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide miRNA profiling reinforces the importance of miR-9 in human papillomavirus associated oral and oropharyngeal head and neck cancer.
Božinović K; Sabol I; Dediol E; Milutin Gašperov N; Manojlović S; Vojtechova Z; Tachezy R; Grce M
Sci Rep; 2019 Feb; 9(1):2306. PubMed ID: 30783190
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNA in head and neck cancer: current knowledge and perspectives.
Courthod G; Franco P; Palermo L; Pisconti S; Numico G
Molecules; 2014 May; 19(5):5704-16. PubMed ID: 24802984
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
9. Role of miRNA in head and neck squamous cell carcinoma.
Masood Y; Kqueen CY; Rajadurai P
Expert Rev Anticancer Ther; 2015 Feb; 15(2):183-97. PubMed ID: 25367254
[TBL] [Abstract][Full Text] [Related]
10. An Update on Cellular MicroRNA Expression in Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma.
Emmett S; Whiteman DC; Panizza BJ; Antonsson A
Oncology; 2018; 95(4):193-201. PubMed ID: 29920485
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus infection in head and neck cancer: the role of the secretory leukocyte protease inhibitor.
Hoffmann M; Quabius ES; Tribius S; Hebebrand L; Görögh T; Halec G; Kahn T; Hedderich J; Röcken C; Haag J; Waterboer T; Schmitt M; Giuliano AR; Kast WM
Oncol Rep; 2013 May; 29(5):1962-8. PubMed ID: 23467841
[TBL] [Abstract][Full Text] [Related]
12. miRNAs in human papilloma virus associated oral and oropharyngeal squamous cell carcinomas.
Salazar C; Calvopiña D; Punyadeera C
Expert Rev Mol Diagn; 2014 Nov; 14(8):1033-40. PubMed ID: 25222489
[TBL] [Abstract][Full Text] [Related]
13. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic insights from genomic studies of head and neck squamous cell carcinomas.
Hammerman PS; Hayes DN; Grandis JR
Cancer Discov; 2015 Mar; 5(3):239-44. PubMed ID: 25643909
[TBL] [Abstract][Full Text] [Related]
15. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G
Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235
[No Abstract] [Full Text] [Related]
16. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM
Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980
[TBL] [Abstract][Full Text] [Related]
17.
Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus and Potentially Relevant Biomarkers in Tonsillar and Base of Tongue Squamous Cell Carcinoma.
Näsman A; Bersani C; Lindquist D; Du J; Ramqvist T; Dalianis T
Anticancer Res; 2017 Oct; 37(10):5319-5328. PubMed ID: 28982840
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
[TBL] [Abstract][Full Text] [Related]
20. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
